Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Guerzoni

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
The Journal of Headache and Pain|October 15, 2011
Proteomic analysis of urine in medication-overuse headache patients: possible relation with renal damagesElisa Bellei, Aurora Cuoghi, Emanuela Monari, et al.
Cephalalgia : an International Journal of Headache|February 9, 2022
Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headacheUmberto Pensato, Carlo Baraldi, Valentina Favoni, et al.
Headache|January 18, 2025
Pharmacological differences and switching among anti-CGRP monoclonal antibodies: A narrative reviewMarina Romozzi, Antonio Munafò, Andrea Burgalassi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 16, 2025
The second interim analysis of Italian participants enrolled in the real-world, Pan-European, prospective, observational, Phase 4 PEARL study of fremanezumab effectivenessFabrizio Vernieri, Anna Ambrosini, Marco Bartolini, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 5, 2021
Real-life assessment of erenumab in refractory chronic migraine with medication overuse headacheUmberto Pensato, Carlo Baraldi, Valentina Favoni, et al.
Neurology and Therapy|February 8, 2024
Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY)Fabrizio Vernieri, Luigi Francesco Iannone, Simona Guerzoni, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 18, 2026
Building bridges in migraine management: consensus pathways on best practices across primary and specialist care in ItalyPiero Barbanti, Cristina Tassorelli, Fabrizio Vernieri, et al.
Frontiers in Neurology|April 16, 2026
Rapid effectiveness of eptinezumab to treat ongoing migraine attacks: preliminary data from an Italian multicenter real-world experience (the BE-FREE study)Luisa Fofi, Claudia Altamura, Marilena Marcosano, et al.
Journal of Neurology|July 19, 2023
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO studyFabrizio Vernieri, Nicoletta Brunelli, Simona Guerzoni, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 7, 2023
Gender-related stress factors and emotional perception in migraine: a structured online questionnaire in migraine patients and controlsMarianna Delussi, Giulia Piraino, Simona Guerzoni, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
The Journal of Headache and Pain|October 15, 2011
Proteomic analysis of urine in medication-overuse headache patients: possible relation with renal damagesElisa Bellei, Aurora Cuoghi, Emanuela Monari, et al.
Cephalalgia : an International Journal of Headache|February 9, 2022
Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headacheUmberto Pensato, Carlo Baraldi, Valentina Favoni, et al.
Headache|January 18, 2025
Pharmacological differences and switching among anti-CGRP monoclonal antibodies: A narrative reviewMarina Romozzi, Antonio Munafò, Andrea Burgalassi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 16, 2025
The second interim analysis of Italian participants enrolled in the real-world, Pan-European, prospective, observational, Phase 4 PEARL study of fremanezumab effectivenessFabrizio Vernieri, Anna Ambrosini, Marco Bartolini, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 5, 2021
Real-life assessment of erenumab in refractory chronic migraine with medication overuse headacheUmberto Pensato, Carlo Baraldi, Valentina Favoni, et al.
Neurology and Therapy|February 8, 2024
Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY)Fabrizio Vernieri, Luigi Francesco Iannone, Simona Guerzoni, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 18, 2026
Building bridges in migraine management: consensus pathways on best practices across primary and specialist care in ItalyPiero Barbanti, Cristina Tassorelli, Fabrizio Vernieri, et al.
Frontiers in Neurology|April 16, 2026
Rapid effectiveness of eptinezumab to treat ongoing migraine attacks: preliminary data from an Italian multicenter real-world experience (the BE-FREE study)Luisa Fofi, Claudia Altamura, Marilena Marcosano, et al.
Journal of Neurology|July 19, 2023
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO studyFabrizio Vernieri, Nicoletta Brunelli, Simona Guerzoni, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 7, 2023
Gender-related stress factors and emotional perception in migraine: a structured online questionnaire in migraine patients and controlsMarianna Delussi, Giulia Piraino, Simona Guerzoni, et al.
Pageof 8